iREACH is an exciting new project for healthcare in Northern Ireland, the outcome of creative collaboration between academia, industry, the NHS and public sector/government stakeholders to drive UK science and innovation, by creating a unique ecosystem for testing new drugs through their development life cycle and integration into care pathways.
The project will build on areas of academic strength where Queen’s University Belfast is globally recognised as a leader, with a focus on five disease areas – cancer, respiratory and eye, including nutrition and metabolism and neurodegenerative areas under accelerated development. Concentration in these areas of expertise will translate into more clinical trials.
This translation of medical research into an increased opportunity for more NHS patients to participate in trials will be truly collaborative between healthcare practitioner, the patient and the public.
iREACH will utilise NHS data to accelerate participation and innovation in clinical studies and increase the opportunities for NHS patients to participate in research. It will also promote the development of healthcare skills in data and technology-related areas to meet the challenges of an effective workforce to the benefit of industry, academia and citizens of NI.
iREACH will create a Health Innovation Hub, providing space for early-stage biotech and med-tech companies. This clustering of research excellence alongside industry expertise will support early adoption and help to generate significant economic benefit for the Belfast Region.